Trial Profile
Randomised, Double-blind, Phase II Evaluation of the Safety and Immunogenicity Following Administration of Live Attenuated JE Vaccine (ChimeriVax-JE) and Yellow Fever Vaccine (STAMARIL).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Feb 2014
Price :
$35
*
At a glance
- Drugs Japanese encephalitis vaccine (Primary) ; Yellow fever vaccine
- Indications Japanese encephalitis; Yellow fever
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi
- 29 Sep 2009 New trial record